[Front line of molecular biological study on and therapy for pulmonary hypertension].
Kuriyama
Takayuki
T
D000818:Animals; D052006:Bone Morphogenetic Protein Receptors, Type II / Q000235:genetics; D004691:Endarterectomy; D004730:Endothelium, Vascular / Q000166:cytology / Q000473:pathology; D011464:Epoprostenol / Q000627:therapeutic use; D005260:Female; D015235:HLA-B Antigens; D059950:HLA-B52 Antigen; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics* / Q000628:therapy*; D008875:Middle Aged; D009154:Mutation; D014665:Vasodilator Agents / Q000627:therapeutic use
D015235:HLA-B Antigens; D059950:HLA-B52 Antigen; D014665:Vasodilator Agents; D011464:Epoprostenol; C498218:BMPR2 protein, human; D052006:Bone Morphogenetic Protein Receptors, Type II